| Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia |
13 |
| Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia |
13 |
| Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a US survey study |
12 |
| Interferon-gamma mediates the immunosuppression of bone marrow mesenchymal stem cells on T-lymphocytes in vitro |
9 |
| Relationship between obesity and iron deficiency anemia: is there a role of hepcidin? |
8 |
| Hyperferritinemia: causes and significance in a general hospital |
8 |
| Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease: analysis of 133 cases from a single center |
8 |
| Efficacy and safety of bispecific T-cell engager (BiTE) antibody blinatumomab for the treatment of relapsed/refractory acute lymphoblastic leukemia and non-Hodgkin's lymphoma: a systemic review and meta-analysis |
8 |
| Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis |
8 |
| Pathogenesis of aplastic anemia |
8 |
| Relapse of childhood acute lymphoblastic leukemia and outcomes at a reference center in Latin America: organomegaly at diagnosis is a significant clinical predictor |
8 |
| TGF-beta 1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells |
7 |
| Prognostic significance of SRSF2 mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia: a meta-analysis |
7 |
| Predictive factors of daily opioid use and quality of life in adults with sickle cell disease |
7 |
| Soluble programmed death-ligand 1 are highly expressed in peripheral T-cell lymphoma: a biomarker for prognosis |
7 |
| Evaluation of hypercoagulability with rotational thromboelastometry in children with iron deficiency anemia |
7 |
| miR-29b inhibits the progression of multiple myeloma through downregulating FOXP1 |
7 |
| Coexisting driver mutations in MPN: clinical and molecular characteristics of a series of 11 patients |
6 |
| Inflammation in deep vein thrombosis: a therapeutic target? |
6 |
| Eltrombopag in the management of aplastic anaemia: real-world experience in a non-trial setting |
6 |
| Investigation of the differences between the Tibetan and Han populations in the hemoglobin-oxygen affinity of red blood cells and in the adaptation to high-altitude environments |
6 |
| Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years |
6 |
| Positron emission tomography computed tomography features of monomorphic epitheliotropic intestinal T-cell lymphoma |
6 |
| Beta-thalassemia: renal complications and mechanisms: a narrative review |
6 |
| Association of GSTT1/GSTM1 and ApoE variants with left ventricular diastolic dysfunction in thalassaemia major patients |
5 |
| Thalidomide has a significant effect in patients with thalassemia intermedia |
5 |
| Outcomes of unplanned tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: retrospective analysis of real-world experience in a single institution |
5 |
| Geographical distribution of beta-globin gene mutations in Syria |
5 |
| Oxidative stress, antioxidant capacity, biomolecule damage, and inflammation symptoms of sickle cell disease in children |
5 |
| Microsatellite Instability and Promoter Hypermethylation of DNA repair genes in Hematologic Malignancies: a forthcoming direction toward diagnostics |
5 |
| Frequency of iron deficiency anemia in pregnant and non-pregnant women suffering from restless legs syndrome |
5 |
| Multidrug resistance 1 (MDR1/ABCB1) gene polymorphism (rs1045642 C > T) and susceptibility to multiple myeloma: a systematic review and meta-analysis |
4 |
| Immune dysregulation in primary immune thrombocytopenia patients |
4 |
| Renal involvement in paroxysmal nocturnal hemoglobinuria: an update on clinical features, pathophysiology and treatment |
4 |
| Synergistic effects of rmhTRAIL and 17-AAG on the proliferation and apoptosis of multiple myeloma cells |
4 |
| Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis |
4 |
| Diagnostic and therapeutic splenectomy for splenic lymphomas: analysis of the National Cancer Data Base |
4 |
| Screening of prognostic risk microRNAs for acute myeloid leukemia |
4 |
| The research progress of circular RNAs in hematological malignancies |
4 |
| Dysfunction of immune system in the development of large granular lymphocyte leukemia |
4 |
| Interactions of unstable hemoglobin Rush with thalassemia and hemoglobin E result in thalassemia intermedia |
4 |
| Knockdown of REG gamma inhibits the proliferation and migration and promotes the apoptosis of multiple myeloma cells by downregulating NF-kappa B signal pathway |
4 |
| Advances in the treatment and prognosis of anaplastic lymphoma kinase negative anaplastic large cell lymphoma |
4 |
| Comparative evaluation of oral and dento-maxillofacial manifestation of patients with sickle cell diseases and beta thalassemia major |
4 |
| Gestational age and childhood leukemia: A meta-analysis of epidemiologic studies |
3 |
| The influence of MTHFR genetic polymorphisms on adverse reactions after methotrexate in patients with hematological malignancies: a meta-analysis |
3 |
| Common themes and challenges in hemophilia care: a multinational perspective |
3 |
| Risk factors of early death in adult patients with secondary hemophagocytic lymphohistiocytosis: a single-institution study of 171 Chinese patients |
3 |
| A systematic literature review on the use of platelet transfusions in patients with thrombocytopenia |
3 |
| Denosumab effects on serum levels of the bone morphogenetic proteins antagonist noggin in patients with transfusion-dependent thalassemia and osteoporosis |
3 |
